Genic (Korea) Investor Sentiment

123330 Stock  KRW 27,150  700.00  2.51%   
About 62% of Genic's investor base is looking to short. The analysis of current outlook of investing in Genic Co suggests that many traders are alarmed regarding Genic's prospects. The current market sentiment, together with Genic's historical and current headlines, can help investors time the market. In addition, many technical investors use Genic stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
Is Akerna Corp a Smart Choice in Drug Manufacturers - Specialty Generic Monday - InvestorsObserver
Google News at Macroaxis
over six months ago at news.google.com         
Middle Rated Pot Stock in the Drug Manufacturers - Specialty Generic Industry Rises 2.74 percent Fri...
Google News at Macroaxis
over a year ago at news.google.com         
Should Drug Manufacturers - Specialty Generic Stock Verano Holdings Corp Be in Your Portfolio Wednes...
Google News at Macroaxis
over a year ago at news.google.com         
Should Drug Manufacturers - Specialty Generic Stock Dynavax Technologies Corp Be in Your Portfolio T...
Google News at Macroaxis
over a year ago at news.google.com         
This Pot Stock is Rated at the Middle of the Drug Manufacturers - Specialty Generic Industry, Should...
Google News at Macroaxis
over a year ago at news.google.com         
Where Does Dynavax Technologies Corp Stock Fall in the Drug Manufacturers - Specialty Generic Field ...
Google News at Macroaxis
over a year ago at news.google.com         
Should You Buy RedHill Biopharma Ltd Stock Tuesday Morning - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
Genesis Welcomes Filippo Vescovi, Vaibhav Padaval and Mason ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Should You Buy SNDL Inc Stock Friday Morning - InvestorsObserver
Google News at Macroaxis
over a year ago at news.google.com         
Is Dynavax Technologies Corp Stock at the Top of the Drug Manufacturers - Specialty Generic Industry...
Google News at Macroaxis
over a year ago at news.google.com         
Everything New on Netflix in December 2023 - ScreenCrush
Google News at Macroaxis
over a year ago at news.google.com         
Genesis Land Development shareholders have earned a 21 percent CAGR over the last three years - Yaho...
Google News at Macroaxis
over a year ago at news.google.com         
Bankrupt Genesis sued by Gemini over 1.6B worth of GBTC shares - Blockworks
Google News at Macroaxis
over a year ago at news.google.com         
Hyundai Motors Q3 net jumps 134 pct on robust sales - Yonhap News Agency
Google News at Macroaxis
over a year ago at news.google.com         
Middle Rated Pot Stock in the Drug Manufacturers - Specialty Generic Industry Drops -4.6 percent Wed...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Genic that are available to investors today. That information is available publicly through Genic media outlets and privately through word of mouth or via Genic internal channels. However, regardless of the origin, that massive amount of Genic data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Genic news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Genic relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Genic's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Genic alpha.

Genic Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Genic Stock analysis

When running Genic's price analysis, check to measure Genic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genic is operating at the current time. Most of Genic's value examination focuses on studying past and present price action to predict the probability of Genic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genic's price. Additionally, you may evaluate how the addition of Genic to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Stocks Directory
Find actively traded stocks across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing